Rune Labs and Aspen Neuroscience Collaborate to Deeply Characterize Symptom Activity in Parkinson’s Disease (PD) for Upcoming Trial-Ready Cohort Screening Study

Rune Labs’ StriveStudy clinical development platform will enable cell therapy company Aspen to remotely collect real-time, longitudinal patient data SAN FRANCISCO, Aug. 24, 2023 /PRNewswire/ — Rune Labs, a precision neurology software and data platform company, and Aspen Neuroscience Inc….

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks